Morgan Stanley upgrades Vir Biotechnology to 'overweight,' raises PT to $20
-- Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased...
-- Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from "equal-weight," and have also increased...
– Saudi Arabia stocks were higher after the close on Thursday, as gains in the Financial Services, Telecoms & IT and Retail sectors led shares higher. At the close...
-- Japan-based Fast Retailing, the operator of the Uniqlo global clothing brand, reported first-quarter results on Thursday, posting a sharp decline in profit in...
- Experian's (LON:EXPN) outlook for margin expansion is "robust" and underpins the potential for sustained organic growth, according to analysts at Morgan Stanley ...
-- Analysts at UBS Global Research have upgraded SSE (LON:SSE) plc's stock rating to "buy" from "neutral,” reflecting improving fundamentals and potential growth in...
(Reuters) - The Volkswagen (ETR:VOWG_p) brand's global deliveries fell 1.4% to 4.8 million vehicles in 2024, with battery-electric sales down around 2.5%, Europe's top carmaker...
(Reuters) - Polestar (NASDAQ:PSNY) on Thursday reported rises in fourth-quarter retail sales and order intake, raising optimism amongst jittery investors over demand for the...
- European corporates announced significant share buyback programs in 2024, and Barclays (LON:BARC) expects this strong buyback activity to continue in 2025. STOXX...
- Higher bond yields are the "main risk" to share prices in the US and will give support to the dollar in the near term, analysts at BCA Research have...
-- Barclays (LON:BARC) has upgraded Partners Group to "overweight,” reflecting increased confidence in its outlook for 2025, in a note dated Thursday. This decision...